Skip to main content
Internal Medicine
ALL Specialities
ALL Specialities
/
Internal Medicine
CME
COVID-19 Updates
Diseases & Conditions
Asthma
Diabetes
Musculoskeletal Disorders
Obesity
Pain
Rare Diseases
Subspecialties
Addiction Medicine
Adolescent Medicine
Cardiology
Critical Care
Dermatology
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
Multimedia
Audio
Podcasts
Video
Business of Medicine
Conference Coverage
FDA panel calls for changes to breast implant rupture screening
Publish date:
March 27, 2019
AT AN FDA ADVISORY PANEL MEETING
mzoler@mdedge.com
Pages
« first
1
2
Recommended Reading
FDA aims to boost safety of platelets for transfusion
MDedge Internal Medicine
Miscarriage after myomectomy depends on fibroid number, uterine incisions
MDedge Internal Medicine
Endometriosis surgery: Women can expect years-long benefits
MDedge Internal Medicine
Carbs vs. fats for CVD
MDedge Internal Medicine
Risk models fail to predict lower-GI bleeding outcomes
MDedge Internal Medicine
President Trump calls for end to HIV/AIDS, pediatric cancer
MDedge Internal Medicine
Conservatism spreads in prostate cancer
MDedge Internal Medicine
Noncardiac surgery has 7% covert stroke rate in elderly
MDedge Internal Medicine
What’s the price of rude behavior in the hospital?
MDedge Internal Medicine
FDA panel leans toward more robust breast implant surveillance
MDedge Internal Medicine
Immunology
Oncology
Women's Health
All Specialties
